Pharmaceuticals

EpiPen Antitrust and RICO Settlement

A partial settlement has been reached in a consolidated class action concerning the marketing and sales of EpiPens, with Pfizer, Inc., Meridian Medical Technologies, Inc., and King Pharmaceuticals, LLC. The complaint alleged the companies violated state antitrust laws and the federal Racketeering and Corrupt Organizations (RICO) Act, harming competition and causing consumers to overpay for  Read more

Pfizer Chantix Stop-Smoking Drug Contains Impurity Class Action

Chantix, a drug made by Pfizer, Inc., is designed to help people stop smoking. Its active ingredient is varenicline. But the complaint for this class action alleges that Chantix contains dangerously high levels of N-nitroso-varenicline, an impurity which is a carcinogen.  Read more

Opioid Epidemic in Kentucky Home Rule Cities Class Action

The opioid crisis is at the heart of this class action, brought by a number of Kentucky home rule cities against pharmaceutical companies, wholesale distributors, and retail pharmacies, including Abbott Laboratories, Teva Pharmaceutical Industries, Ltd., Allergan, plc, CVS Health Corporation, Rite Aid Corporation, and Walmart, Inc. The complaint alleges that the companies engaged in a  Read more

Elmiron Patients and Medical Monitoring Massachusetts Class Action

The defendants in this class action are a number of pharmaceutical companies (such as Teva Pharmaceuticals USA, Inc., Janssen Pharmaceuticals, Inc., and Johnson & Johnson) who have made, promoted or sold a drug called Elmiron. Elmiron is intended to treat interstitial cystitis, which is known as IC or bladder pain syndrome. However, the complaint for  Read more

Walgreens “Usual & Customary” Generic Drug Prices Class Action

This class action alleges that Walgreens artificially inflates its “usual and customary” prices on certain generic prescription drugs. The complaint claims that Walgreens charges lower prices for the drugs to its cash-paying customers who do not have health insurance, if they enroll in something it calls its Prescription Savings Club (PSC).  Read more

Picato Gel Alleged to Be “Worthless” Class Action

Does Picato gel increase the risk of squamous cell skin cancer? The complaint for this class action says it does and declares the medicine “defectively manufactured and unfit for [its] intended purpose[.]” It brings suit against LEO Pharma, Inc. and LEO Pharma AS for breach of the implied warranty of merchantability, claiming that Picato is  Read more

McKinsey Helped Purdue Increase OxyContin Sales Alabama Class Action

This complaint is brought by a county and city in Alabama against McKinsey & Company, Inc. and two related McKinsey companies on the subject of opioids, citing “significantly increased costs, as well as a dramatic increase of social problems, including … drug abuse and the commission of criminal acts to obtain opioids.” The complaint says  Read more

Manufacturers, Distributors, Pharmacies Opioid Epidemic RICO Case

A very large multi-district litigation (MDL) case on opioids is currently working its way through the court system, with multiple complaints, long lists of defendants, and around 3,500 documents currently on file. The complaints bring suit against a group of manufacturers, marketers, distributors, national pharmacies, and pharmacy benefit managers, for creating or contributing to the  Read more

Sanguenol ED Supplement Alleged to Be Unapproved Drug Class Action

If a company claims that its supplements are for “the prevention, cure, mitigation, and therapeutic treatment of disease,” then they are considered to be drugs and must be regulated and approved by the Food and Drug Administration (FDA). The complaint for this class action alleges that North American Nutraceuticals, LLC has been selling “illegal, unapproved  Read more

Jazz Pharmaceuticals Anticompetitive Agreements on Xyrem Class Action

In recent years, we’ve seen a number of antitrust cases where a pharmaceutical company with a lucrative drug is accused of conspiring with generics companies to keep generic versions of that drug off the market. This class action alleges that Jazz Pharmaceuticals, related Jazz companies, and a long list of other drug companies conspired to  Read more